Skip to main content

Table 2 Content of ethical review of journals of Q1 section versus journals of Q2-Q4 section

From: Ethical requirements of instructions for authors of complementary and alternative medicine journals: a cross-sectional study

Content

Geographic origin

JCR Quartile rankings

Year of electronic JCR

Types of studies

% of OA Gold

Total

European and American area

Asia

P value*

Q1

Q2-Q4

P value*

< 11.93

≥ 11.93

P value*

original research

additional key words#

P value*

< 8.99%

≥ 8.99%

P value*

Declaration of Helsinki (%)

 

yes

22(81.5)

18(81.8)

4(18.2)

0.091

6(27.3)

16(72.7)

0.555

12(54.5)

10(45.5)

1.000

10(45.5)

12(54.5)

0.618

10(45.5)

12(54.5)

0.326

no

5(18.5)

2(40.0)

3(60.0)

 

0(0.0)

5(100.0)

 

3(60.0)

2(40.0)

 

1(20.0)

4(80.0)

 

4(80.0)

1(20.0)

 

ICMJE Recommendations (%)

 

yes

19(70.4)

15(78.9)

4(21.1)

0.633

4(21.1)

15(78.9)

1.000

11(57.9)

8(42.1)

1.000

7(36.8)

12(63.2)

0.675

9(47.4)

10(52.6)

0.678

no

8(29.6)

5(62.5)

3(37.5)

 

2(25.0)

6(75.0)

 

4(50.0)

4(50.0)

 

4(50.0)

4(50.0)

 

5(62.5)

3(37.5)

 

COPE core practice (%)

 

yes

24(88.9)

17(70.8)

7(29.2)

0.545

6(25.0)

18(75.0)

1.000

14(58.3)

10(41.7)

0.569

11(45.8)

13(54.2)

0.248

12(50.0)

12(50.0)

1.000

no

3(11.1)

3(100.0)

0(0.0)

 

0(0.0)

3(100.0)

 

1(33.3)

2(66.7)

 

0(0.0)

3(100.0)

 

2(66.7)

1(33.3)

 

IRB approval(%)

 

yes

18(66.7)

14(77.8)

4(22.2)

0.653

2(11.1)

16(88.9)

0.136

10(55.6)

8(44.4)

1.000

6(33.3)

12(66.7)

0.411

7(38.9)

11(61.1)

0.103

no

9(33.3)

6(66.7)

3(33.3)

 

4(44.4)

5(55.6)

 

5(55.6)

4(44.4)

 

5(55.6)

4(44.4)

 

7(38.9)

2(22.2)

 

IRB number(%)

 

yes

7(25.9)

6(85.7)

1(14.3)

0.633

3(42.9)

4(57.1)

0.290

5(71.4)

2(28.6)

0.408

5(71.4)

2(28.6)

0.084

2(28.6)

5(71.4)

0.209

no

20(74.1)

14(70.0)

6(30.0)

 

3(15.0)

17(85.0)

 

10(50.0)

10(50.0)

 

6(30.0)

14(70)

 

12(60.0)

8(40.0)

 

IRB name(%)

 

yes

10(37.0)

8(80.0)

2(20.0)

0.678

3(30.0)

7(70.0)

0.638

7(70.0)

3(30.0)

0.424

6(60.0)

4(40.0)

0.224

4(40.0)

6(60.0)

0.440

no

17(63.0)

12(70.6)

5(29.4)

 

3(17.6)

14(82.4)

 

8(47.1)

9(52.9)

 

5(29.4)

12(70.6)

 

10(58.8)

7(41.2)

 

Registration (%)

 

yes

18(66.7)

15(83.3)

3(16.7)

0.175

3(16.7)

15(83.3)

0.367

10(55.6)

8(44.4)

1.000

6(33.3)

12(66.7)

0.411

10(55.6)

8(44.4)

0.695

no

9(33.3)

5(55.6)

4(44.4)

 

3(33.3)

6(66.7)

 

5(55.6)

4(44.4)

 

5(55.6)

4(44.4)

 

4(44.4)

5(55.6)

 

Reporting guidelines (%)

 

yes

19(70.4)

16(84.2)

3(15.8)

0.145

4(21.1)

15(78.9)

1.000

10(52.6)

9(47.4)

0.696

7(36.8)

12(63.2)

0.675

10(52.6)

9(47.4)

1.000

no

8(29.6)

4(50.0)

4(50.0)

 

2(25.0)

6(75.0)

 

5(62.5)

3(37.5)

 

4(50.0)

4(50.0)

 

4(50.0)

4(50.0)

 

Informed consent(%)

 

yes

22(81.5)

17(77.3)

5(22.7)

0.580

6(27.3)

16(72.7)

0.555

11(50.0)

11(50.0)

0.342

10(45.5)

12(54.5)

0.618

10(45.5)

12(54.5)

0.326

no

5(18.5)

3(60.0)

2(40.0)

 

0(0.0)

5(100.0)

 

4(80.0)

1(20.0)

 

1(20.0)

4(80.0)

 

4(80.0)

1(20.0)

 

Images policy(%)

 

yes

14(51.9)

11(78.6)

3(21.4)

0.678

2(14.3)

12(85.7)

0.385

8(57.1)

6(42.9)

1.000

4(28.6)

10(71.4)

0.252

7(50.0)

7(50.0)

1.000

no

13(48.1)

9(69.2)

4(30.8)

 

4(30.8)

9(69.2)

 

7(53.8)

6(46.2)

 

7(53.8)

6(46.2)

 

7(53.8)

6(46.2)

 

Data sharing(%)

 

yes

21(77.8)

16(76.2)

5(23.8)

0.633

6(28.6)

15(71.4)

0.284

13(6.9)

8(38.1)

0.357

10(47.6)

11(52.4)

0.350

9(42.9)

12(57.1)

0.165

no

6(22.2)

4(66.7)

2(33.3)

 

0(0.0)

6(100.0)

 

2(33.3)

4(66.7)

 

1(16.7)

5(83.3)

 

5(83.3)

1(16.7)

 
  1. *Fisher’s exact test
  2. #with key words of randomized controlled trials, case report, protocol, pilot study, clinical trials, etc